BVF »

Vistagen Therapeutics Ord shares owned by BVF

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by BVF from 13F filings

Historical chart of BVF investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by BVF

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 2.0M 5.14

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Revolution Medicines (RVMD)
Axsome Therapeutics (AXSM)
Protagonist Therapeutics (PTGX)
Kymera Therapeutics (KYMR)
Mirum Pharmaceuticals (MIRM)
Olema Pharmaceuticals (OLMA)
Ionis Pharmaceuticals (IONS)
Kura Oncology (KURA)
4d Molecular Therapeutics In (FDMT)
Galapagos Nv Spon Adr (GLPG)
Merus N V (MRUS)
Repare Therapeutics Ord (RPTX)
Ac Immune Sa SHS (ACIU)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for BVF

Top funds holding Vistagen Therapeutics Ord

BVF
Dr. Jeffrey R. Jay, M.D.
Nantahala Capital Management
Vanguard Group
Commodore Capital
Citadel Advisors
Sphera Funds Management
Susquehanna International
BlackRock
ADAR1 Capital Management
Two Sigma Investments
Goldman Sachs Group
BML Capital Management
Bank Of Montreal
Gts Securities

View all funds holding Vistagen Therapeutics Ord